Paper8399397
Influence of tryptophan residues on melittin's hemolytic activity.
Blondelle SE and 3 others. Biochim Biophys Acta, 1993. Cited by 72 papers, by iCite.
Cite this record
ConductScience Library. Influence of tryptophan residues on melittin's hemolytic activity. Papers, record 8399397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8399397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hemolysis | Major topic |
| Melitten | Major topic |
| Tryptophan | Major topic |
| Amino Acid Sequence | |
| Chromatography, High Pressure Liquid | |
| Circular Dichroism | |
| Dose-Response Relationship, Drug | |
| Erythrocytes | |
| Humans | |
| Molecular Sequence Data | |
| Oligopeptides | |
| Software |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GM45583 | NIGMS NIH HHS | United States | R01GM045583 | PubMed and NIH |
Source NIH RePORTER
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42514918 | Multidimensional Modification and Functional Optimization of Melittin: From Natural Toxic Peptide to Safe and Effective Therapeutics. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514918 | PubMed |
| 41156814 | Targeted Modification of the Antimicrobial Peptide DGL13K Reveals a Naturally Optimized Sequence for Topical Applications. | Microorganisms | 2025 | https://conductscience.org/library/papers/41156814 | PubMed |
| 38017537 | Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/38017537 | PubMed |
| 37298407 | Peptide-Based Nanoparticles for Systemic Extrahepatic Delivery of Therapeutic Nucleotides. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298407 | PubMed |
| 36518867 | Rational Design of a Hybrid Peptide against Severe Acute Respiratory Syndrome Coronavirus 2 Using Melittin and Angiotensin-Converting Enzyme 2 as Pharmaceutical Agents. | Adv Biomed Res | 2022 | https://conductscience.org/library/papers/36518867 | PubMed |
| 35878166 | Melittin Tryptophan Substitution with a Fluorescent Amino Acid Reveals the Structural Basis of Selective Antitumor Effect and Subcellular Localization in Tumor Cells. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/35878166 | PubMed |
| 35337121 | Traditional and Computational Screening of Non-Toxic Peptides and Approaches to Improving Selectivity. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35337121 | PubMed |
| 32629881 | Analogues of a Cyclic Antimicrobial Peptide with a Flexible Linker Show Promising Activity against Pseudomonas aeruginosa and Staphylococcus aureus | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/32629881 | PubMed |
| 32528474 | Strategies in Translating the Therapeutic Potentials of Host Defense Peptides. | Front Immunol | 2020 | https://conductscience.org/library/papers/32528474 | PubMed |
| 28468662 | Heterologous expression of abaecin peptide from Apis mellifera in Pichia pastoris. | Microb Cell Fact | 2017 | https://conductscience.org/library/papers/28468662 | PubMed |
| 23935838 | A proline-hinge alters the characteristics of the amphipathic α-helical AMPs. | PLoS One | 2013 | https://conductscience.org/library/papers/23935838 | PubMed |
| 21860239 | Clinical efficacy of a specifically targeted antimicrobial peptide mouth rinse: targeted elimination of Streptococcus mutans and prevention of demineralization. | Caries Res | 2011 | https://conductscience.org/library/papers/21860239 | PubMed |
| 20335225 | Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures. | FASEB J | 2010 | https://conductscience.org/library/papers/20335225 | PubMed |
| 17905846 | Conformational sampling of peptides in cellular environments. | Biophys J | 2008 | https://conductscience.org/library/papers/17905846 | PubMed |
| 16255716 | Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori. | Biochem J | 2006 | https://conductscience.org/library/papers/16255716 | PubMed |
| 12168695 | Structure and activity of D-Pro14 melittin. | J Protein Chem | 2002 | https://conductscience.org/library/papers/12168695 | PubMed |
| 9971832 | A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. | J Virol | 1999 | https://conductscience.org/library/papers/9971832 | PubMed |
| 8687396 | Dimerization of truncated melittin analogues results in cytolytic peptides. | Biochem J | 1996 | https://conductscience.org/library/papers/8687396 | PubMed |
| 8546675 | Rapid identification of compounds with enhanced antimicrobial activity by using conformationally defined combinatorial libraries. | Biochem J | 1996 | https://conductscience.org/library/papers/8546675 | PubMed |
| 8172621 | Determination of the secondary structure of selected melittin analogues with different haemolytic activities. | Biochem J | 1994 | https://conductscience.org/library/papers/8172621 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8399397
GET https://conductscience.org/api/papers/v1/8399397/cited_by?page=2